To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro-(S)-C-5-branched [4.3.1] aza-amide bicycles was developed. The key step of the synthesis is an HF-driven N-acyliminium cyclization. Functionalization of the C(5)moiety resulted in novel protein contacts with the psychiatric risk factor FKBP51, which led to a more than 280-fold enhancement in affinity. The most potent ligands facilitated the differentiation of N2a neuroblastoma cells with low nanomolar potency
In recent years the FK506-binding protein 51 (FKBP51) has emerged as a potential target for treating...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro...
FK506-binding proteins (FKBPs) have emerged as a promising drug target due to their role in various ...
A stereoselective synthesis of a derivatized bicyclic [4.3.1]decane scaffold based on an acyclic pre...
The FK506-binding protein 51 (FKBP51) has emerged as an attractive new drug target for mood disorder...
Selective inhibition of FKBP51 has emerged as possible novel treatment for diseases like major depre...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
The FK506-binding protein 51 (FKBP51, encoded by the FKBP5 gene) is an established risk factor for s...
The FK506-binding protein 51 (FKBP51) plays an important role in steroid hormone receptors (SHRs) re...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
In recent years the FK506-binding protein 51 (FKBP51) has emerged as a potential target for treating...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro...
FK506-binding proteins (FKBPs) have emerged as a promising drug target due to their role in various ...
A stereoselective synthesis of a derivatized bicyclic [4.3.1]decane scaffold based on an acyclic pre...
The FK506-binding protein 51 (FKBP51) has emerged as an attractive new drug target for mood disorder...
Selective inhibition of FKBP51 has emerged as possible novel treatment for diseases like major depre...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
The FK506-binding protein 51 (FKBP51, encoded by the FKBP5 gene) is an established risk factor for s...
The FK506-binding protein 51 (FKBP51) plays an important role in steroid hormone receptors (SHRs) re...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
In recent years the FK506-binding protein 51 (FKBP51) has emerged as a potential target for treating...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...